News

Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressure
AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...
exchange4media26m
Rikki Jones becomes AstraZeneca’s Head of Communications, International & EUCAN
Seasoned communications leader Rikki Jones joins biopharmaceutical giant AstraZeneca as Head of Communications, International ...
AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...
ZAWYA54m
AstraZeneca enters rare disease care in South Africa
For many rare disease patients and their families, this often results in years of uncertainty, misdiagnosis, and limited or ...
Why AstraZeneca Stock Was Topping the Market on Tuesday
Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.
BioSpace2d
AstraZeneca CEO Says World ‘Needs to Share’ in Global Pharma R&D
Pascal Soriot's comments came during AstraZeneca's Q2 earnings call in regard to President Donald Trump’s newly announced ...
AstraZeneca Profit, Revenue Lifted by Cancer Drugs
AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer ...
InsideNoVa on MSN9d
AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobs
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
AstraZeneca's rare immune disorder drug succeeds in advanced trial
AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...
AstraZeneca to invest $50B in US economy by 2030
British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...